Satoh M, Oguro R, Yamanaka C, Takada K, Matsuura Y, Akiba T, et al. Clinical Assessment of Bortezomib for Multiple Myeloma in Comparison with Thalidomide. J Pharm Pharm Sci [Internet]. 2011 Feb. 19 [cited 2024 Sep. 17];14(1):78-89. Available from: https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/8892